中文 | English
Return
Total: 288 , 1/29
Show Home Prev Next End page: GO
Author:(Xiao-Gang ZHENG)

1.Advances in novel anti-HIV-1 drugs and drug candidates: 2005-2008.

Purong ZHENG ; Hai XUE ; Zhiyan XIAO ; Gang LIU

Acta Pharmaceutica Sinica 2010;45(2):154-64

2.Immune reconstitution inflammatory syndrome and its risk factors in highly active antiretroviral therapy

Guoqiang ZHOU ; Min WANG ; Yuhuang ZHENG ; Meng LIU ; Gang XIAO

Chinese Journal of Clinical Infectious Diseases 2010;03(4):213-216

3.Effect of flavopiridol on the proliferation, invasiveness and apoptosis of human prostatic cancer cell line LNCaP

Ning LI ; Gang LIANG ; Hong XIAO ; Huixia ZHENG ; Jianfang LIANG

Cancer Research and Clinic 2016;28(6):366-368,372

4.The effect of high intensity focused ultrasound on VEGF and PCNA expression and apoptosis of subcutane-ous neurogliocytoma in nude mice

Wengfeng XIAO ; Jun LI ; Gang HUO ; Anlin ZHAI ; Lvping ZHENG

Chinese Journal of Nervous and Mental Diseases 2015;(7):416-421

5.Comparison on eye biometry of Lenstar 900, A-scan ultrasound and keratometer in patients with cataract

Dan, HU ; Gang-Ping, ZHAO ; Jian-Hong, YU ; Xiao, ZHENG

International Eye Science 2014;(8):1440-1443

6.Clinicopathological study of lymph node micrometastasis in patients with early gastric cancer

xiao-yan, WANG ; ren-da, BI ; xiao-long, JIN ; zheng-gang, ZHU

Journal of Shanghai Jiaotong University(Medical Science) 2006;0(05):-

7.The study on clinical manifestations and T lyphokine levels of HAART associated immune reconstitution inflammatory syndrome

Guoqiang ZHOU ; Yuhuang ZHENG ; Meng LIU ; Min WANG ; Gang XIAO ; Yan HE ; Huaying ZHOU ; Zi CHEN

Journal of Chinese Physician 2010;12(9):1158-1161

10.Down-regulation of arginase-1 expression and its clinical significance in hepatocellular carcinoma

Chunyan GU ; Feng XIAO ; Zheng QIAN ; Jianguo SHAO ; Gang QIN ; Li CHEN

China Oncology 2014;(6):438-445

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 288 , 1/29 Show Home Prev Next End page: GO